|
|
Blood, 15 January 2006, Vol. 107, No. 2, pp. 651-654.
Prepublished online as a Blood First Edition Paper on September 22, 2005; DOI 10.1182/blood-2005-03-1025.
Previous Article | Table of Contents | Next Article 
IMMUNOBIOLOGY Brief report
Alkylamines cause V 9V 2 T-cell activation and proliferation by inhibiting the mevalonate pathway
Keith Thompson,
Javier Rojas-Navea, and
Michael J. Rogers
From the Bone Research Group, University of Aberdeen, Institute of Medical Sciences, Foresterhill, Aberdeen, United Kingdom.
Three general classes of small, nonpeptide "antigens" activate V 9V 2 T cells: pyrophosphomonoesters, such as isopentenyl diphosphate (IPP), nitrogen-containing bisphosphonates (N-BPs), and alkylamines. However, we have shown recently that N-BPs indirectly activate V 9V 2 T cells as a consequence of inhibition of farnesyl diphosphate synthase (a key enzyme of the mevalonate pathway) and the intracellular accumulation of IPP. We now show that alkylamines activate V 9V 2 T cells by the same mechanism. Alkylamines were found to be weak inhibitors of farnesyl diphosphate synthase and caused accumulation of unprenylated Rap1A in peripheral blood mononuclear cells and macrophages, indicative of inhibition of the mevalonate pathway. Furthermore, as with N-BPs, the stimulatory effect of the alkylamines on V 9V 2T cells was abrogated by simultaneous treatment with mevastatin. These findings suggest that only pyrophosphomonoesters such as IPP are true V 9V 2 T-cell agonists, whereas alkylamines and N-BPs indirectly activate V 9V 2 T cells through a common mechanism involving the accumulation of IPP.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Holderness, L. Jackiw, E. Kimmel, H. Kerns, M. Radke, J. F. Hedges, C. Petrie, P. McCurley, P. M. Glee, A. Palecanda, et al.
Select Plant Tannins Induce IL-2R{alpha} Up-Regulation and Augment Cell Division in {gamma}{delta} T Cells
J. Immunol.,
November 15, 2007;
179(10):
6468 - 6478.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-J. Puan, C. Jin, H. Wang, G. Sarikonda, A. M. Raker, H. K. Lee, M. I. Samuelson, E. Marker-Hermann, L. Pasa-Tolic, E. Nieves, et al.
Preferential recognition of a microbial metabolite by human V{gamma}2V{delta}2 T cells
Int. Immunol.,
May 1, 2007;
19(5):
657 - 673.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Thompson and M. J. Rogers
Bisphosphonates and {gamma}{delta} T-Cells: New Insights into Old Drugs
IBMS BoneKEy,
August 1, 2006;
3(8):
5 - 13.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Kato, Y. Tanaka, M. Hayashi, K. Okawa, and N. Minato
Involvement of CD166 in the Activation of Human {gamma}{delta}T Cells by Tumor Cells Sensitized with Nonpeptide Antigens
J. Immunol.,
July 15, 2006;
177(2):
877 - 884.
[Abstract]
[Full Text]
[PDF]
|
 |
|
| |